BioCentury
ARTICLE | Clinical News

Eurocine preclinical data

June 25, 2012 7:00 AM UTC

In mice intranasally challenged with pneumococcal bacteria, Eurocine's intranasal pneumococcal glycoconjugate vaccine plus Endocine adjuvant significantly protected mice from infection vs. the vaccine alone. Additionally, Eurocine said the adjuvanted vaccine displayed the same level of protection as that of the active control Prevnar 13. The vaccine is a monovalent pneumococcal polysaccharide serotype 1 conjugate, while the company's Endocine is a vaccine adjuvant composed of endogenous lipids found in the human body. ...